As of mid-August 2026, the CDC reports 2,566 confirmed U.S. measles cases year-to-date—already surpassing the full-year 2025 total of 2,289—with 38 new outbreaks and 94% of cases linked to ongoing transmission chains. Sustained spread stems from sub-95% MMR vaccination coverage in certain communities, enabling rapid propagation of the highly contagious virus (basic reproduction number 12–18) via imported index cases and local clusters, particularly among unvaccinated children and young adults. Official CDC weekly surveillance updates, alongside state health department reports on case counts, hospitalizations (currently 7%), and outbreak resolution, represent the primary near-term data releases that could shift trader assessments of final 2026 totals and elimination-status risks.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้วผู้ป่วยโรคหัดในสหรัฐอเมริกาในปี 2026?
ผู้ป่วยโรคหัดในสหรัฐอเมริกาในปี 2026?
$7,831,656 ปริมาณ
$7,831,656 ปริมาณ
Dec 31, 2026
↑4.5k
42%
↑3k
94%
↑3.5k
92%
↑4k
75%
↑5k
26%
↑7.5k
12%
↑10k
5%
↑12.5k
5%
$7,831,656 ปริมาณ
$7,831,656 ปริมาณ
Dec 31, 2026
↑4.5k
$20 ปริมาณ
42%
↑3k
$90,114 ปริมาณ
94%
↑3.5k
$13,530 ปริมาณ
92%
↑4k
$221,013 ปริมาณ
75%
↑5k
$230,428 ปริมาณ
26%
↑7.5k
$185,064 ปริมาณ
12%
↑10k
$6,515,805 ปริมาณ
5%
↑12.5k
$349,917 ปริมาณ
5%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of mid-August 2026, the CDC reports 2,566 confirmed U.S. measles cases year-to-date—already surpassing the full-year 2025 total of 2,289—with 38 new outbreaks and 94% of cases linked to ongoing transmission chains. Sustained spread stems from sub-95% MMR vaccination coverage in certain communities, enabling rapid propagation of the highly contagious virus (basic reproduction number 12–18) via imported index cases and local clusters, particularly among unvaccinated children and young adults. Official CDC weekly surveillance updates, alongside state health department reports on case counts, hospitalizations (currently 7%), and outbreak resolution, represent the primary near-term data releases that could shift trader assessments of final 2026 totals and elimination-status risks.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
ตลาดเปิดเมื่อ: Feb 16, 2026, 11:51 AM ET
ปริมาณการซื้อขาย
$7,831,656วันสิ้นสุด
Dec 31, 2026ตลาดเปิดเมื่อ
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of mid-August 2026, the CDC reports 2,566 confirmed U.S. measles cases year-to-date—already surpassing the full-year 2025 total of 2,289—with 38 new outbreaks and 94% of cases linked to ongoing transmission chains. Sustained spread stems from sub-95% MMR vaccination coverage in certain communities, enabling rapid propagation of the highly contagious virus (basic reproduction number 12–18) via imported index cases and local clusters, particularly among unvaccinated children and young adults. Official CDC weekly surveillance updates, alongside state health department reports on case counts, hospitalizations (currently 7%), and outbreak resolution, represent the primary near-term data releases that could shift trader assessments of final 2026 totals and elimination-status risks.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
ปริมาณการซื้อขาย
$7,831,656วันสิ้นสุด
Dec 31, 2026ตลาดเปิดเมื่อ
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...As of mid-August 2026, the CDC reports 2,566 confirmed U.S. measles cases year-to-date—already surpassing the full-year 2025 total of 2,289—with 38 new outbreaks and 94% of cases linked to ongoing transmission chains. Sustained spread stems from sub-95% MMR vaccination coverage in certain communities, enabling rapid propagation of the highly contagious virus (basic reproduction number 12–18) via imported index cases and local clusters, particularly among unvaccinated children and young adults. Official CDC weekly surveillance updates, alongside state health department reports on case counts, hospitalizations (currently 7%), and outbreak resolution, represent the primary near-term data releases that could shift trader assessments of final 2026 totals and elimination-status risks.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว
ระวังลิงก์ภายนอก
ระวังลิงก์ภายนอก
คำถามที่พบบ่อย